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1. Introduction 
The haemagglutinin is the major glycoprotein of 
the influenza virus membrane. We have reported [l] 
that in cell-free protein synthesising systems prepared 
from wheat germ or from L cells, translation of 
haemagglutinin messenger RNA leads to the produc- 
tion of two haemagglutinin precursor polypeptides. 
In both systems a 63 000 dalton precursor was pro- 
duced and in the L cell system a 75 000 dalton com- 
ponent was also detected. The synthesis of the latter 
precursor was enhanced by the addition of microso- 
mal membranes to either cell free system and further- 
more under these conditions of translation this poly- 
peptide was shown to be glycosylated and to be 
included within the added membrane vesicles. Here, 
the results of analyses of the amino-terminal sequences 
of these two haemagglutinin precursors are reported. 
In addition the partial amino acid sequence of the 
63 000 dalton component is confirmed and the com- 
plete amino-terminal sequence is deduced from the 
results of nucleotide sequence analyses of the virion 
RNA which is complementary in sequence to the 
haemagglutinin messenger RNA. 
2. Methods 
The conditions for cell-free protein synthesis were 
as in [ 1,2]. L-[4,5-3H] Leucine (100 Ci/mmol), 
L-[4,5-3H]isoleucine (80 Ci/mmol), L-[3,4 (n) -3H]- 
valine (15 Ci/mmol) or L-[35S]methionine (2000 
Ci/mmol) from the Radiochemical Centre, Amersham, 
were added separately to wheat germ or nuclease- 
treated L-cell extracts containing RNA extracted 
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from primary chick embryo fibroblasts infected 
with A/Japan/305/57 (H2Nl) influenza virus. A por- 
tion of the [35S]methionine-labelled translation prod. 
uct was added to each [3H]amino acid-labelled prod- 
uct and the polypeptides were separated by electro- 
phoresis in 7.5% polyacrylamide gels. The gels were 
autoradiographed wet and the radioactive haemag- 
glutinin precursors were eluted from the gel bands. 
Following addition of carrier myoglobin (85 nmol) 
the labelled polypeptides were precipitated and their 
amino acid sequence determined as in [a]. Virion 
RNAs were labelled at their 3’-termini using cytidine 
3’,5’-[5’-32P]bisphosphate from the Radiochemical 
Centre, Amersham and T4 -RNA ligase (P-L Biochem- 
icals) as in [3] and subsequently purified by poly- 
acrylamide gel electrophoresis [4]. Nucleotide 
sequence determinations were by the procedure in 
[51. 
3. Results and discussion 
The amino-terminal sequence of the 75 000 dalton 
glycosylated precursor has isoleucine residues at posi- 
tions 3 and 5 equivalent to those of the HA, poly- 
peptide component of the haemagglutinin from virus 
particles [6]. This was determined using [3H]isoleu- 
tine-labelled material produced in an L cell system 
containing dog pancreas microsomal membranes 
(fig.lA). The amino-terminal sequence of the [3H]- 
isoleucine-labelled 63 000 dalton precursor produced 
in an L cell system without added membranes was, 
however, quite different since radioactivity was 
detected in residues 2,3, 5,6, 17 and 19 (fig.lD). 
In subsequent experiments the amino-terminal 
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sequence of the 63 000 dalton polypeptide produced 
in wheat germ extracts was analyzed and the results 
shown in fig.lB,C were obtained. In [3H]leucine- and 
[3H]valine-labelled products leucine residues were 
detected at positons 5,7 and 8 and valine at position 
12. In contrast to the results obtained for the amino- 
terminal sequence of the 63 000 dalton product of 
the L cell system these results indicate that leucine 
rather than isoleucine is present at position 5. How- 
ever, since it can also be seen from the results in fig.1 D 
that the yield of [3H]isoleucine from the 63 00 dalton 
L cell system product in cycle 3 was -2-times that 
obtained in cycle 5 it is possible that a mixture of 
polypeptides with the amino-terminal sequences of 
both the 75 000 dalton and the 63 000 dalton pre- 
cursors was present in this product. If this is the case 
then the partial amino-terminal sequence of the 
63 000 dalton haemagglutinin precursor is: 
NH2 -?-Ile-Ile-?-I..eu-Ile-Leu-Leu-?-?-?- 
Val-?-?-?-?-Ile-?-Ile- 
Furthermore since the isoleucine residues at positions 
17 and 19 of this precursor have the same spacing as 
those at positions 3 and 5 of the viral HA1 polypep- 
tide, the primary translation product of haemag- 
glutinin messenger RNA appears to contain an amino- 
terminal extension 14 amino acids in length. 
The results of the nucleotide sequence analysis 
presented in fig.2 support this proposal. Since the 
sequence determined is complementary to that of the 
haemagglutinin mRNA, the first initiation codon is at 
residues 44-46 (fig.3) and the nucleotide sequence 
data indicate the sequence of the amino-terminal 45 
amino acid residues. The protein sequence thus 
deduced confirms the partial amino acid sequence 
Fig.1. Ammo-terminal sequence analysis of influenza virus 
haemagglutinin synthesised in vitro. The recovery of [3H]- 
amino acid at each cycle of Edman degradation in the auto- 
matic sequencer for the following preparations was 
obtained by the methods in [ 111. (a) [ 3H] Isoleucine-labelled 
75 000 dalton glycosylated precursor synthesised in L cell 
extracts in the presence of microsomal membranes. (b) 
[ 3H]Leucine-labelled 63 000 dalton precursor synthesised in 
wheat germ extracts. (c) [3H]Valine-labelled 63 000 dalton 
precursor synthesised in wheat germ extracts. (d) [3H]Iso- 
leucine-labelled 63 000 dalton precursor synthesised in 
L cell extracts. 
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UCGUUUUCGUCCACAAUAUGGUAUCUGUUG 
AGCAAAAGCAGGUGUUAUPCCAUAGACAAC 
40 50 60 
GUUUUCGUUUUGUUACCGGUAGUPPAUAGA 
C A A A A G C A A A A C P A U G,G C C,F U C.A U U,U A U,C U 
Met Ala IlIZ 1le Tyr LeU 
70 80 90 
GUAAGAGGACAAGUGUCGUCPCUCUCCCCU 
C,A U U,C U C,C U G,U U C,A C A,G C A,G U G,P G A,G G G,G A 
1le Leu Leu Phe Thr Ala va1 Ar9 Gly Asp 
100 110 120 
GGUCUAUACGUAACCUPUGGUP CGGUUAUU 
C,C A G,A U A,U G C,A U U,G G A,U A C,C A U,G C C,A A U,P A 
Gln Ile cys 1le Gly wr His Ala AStl Psn 
130 140 150 
AAGGUGUCUCUUCCPGCUGUGUUAAGAUCU 
U,U C C,A C A,G A G,A A G,G 11 C,G A C,A C A,P U U,C U A,G P 
Ser Thr Glu LYS Val ASP Thr 1le LeU Glu 
160 170 180 
CGCCUUGCAGUGACACUGAGUACCGGC 
G,C G G,A A C,G U C,A C U,G U G,A C U,C A U,G G C,C G 
kg ASll Val Thr Val Thr His Gly Arg 
Fig.3. The 3’-terminal nucleotide sequence of the haemagglutinin gene, its complement and the amino-terminal sequence of the 
haemagglutinin. 
determined for the 63 000 dalton component pre- 
sented above with the provision that the initiator 
methionine residue is removed in vitro. In addition the 
nucleotide sequence establishes that the isoleucine 
residues detected at positions 17 and 19 of this com- 
ponent are equivalent to residues 3 and 5 of the 
HA1 polypeptide isolated from virus particles. The 
ammo acid sequence following the 14 residue amino- 
terminal extension is in agreement with that obtained 
by amino acid sequence analysis of the HA1 polypep- 
tide ([6], unpublished results). 
The results presented here, therefore, indicate that 
the haemagglutinin of the influenza virus membrane 
is synthesized as a precursor which contains a hydro- 
phobic amino terminal sequence not present in the 
virion glycoprotein. They support the concept of 
common initial events in the biosynthesis of secre- 
tory [7] and membrane proteins [8,9] according to 
which the hydrophobic amino-terminal extension 
may function as a signal peptide in facilitating asso- 
ciation of the haemagglutinin precursor with the 
endoplasmic reticulum and its subsequent trans-mem- 
Fig.2. Autoradiograph of the cleavage products of 3’-terminal labelled gene 4 of influenza virus. Reaction conditions were 
those in [5]. The cleavage products of the 4 reactions were fractionated by electrophoresis at 2000 V in gels which contained 
either (a) 12% acrylamide, 0.6% bisacrylamide, or (b) 8% acrylamide, 0.4% bisacrylamide. The gel dimensions were 960 X 200 X 
0.5 mm. 
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brane movement. Taken together the nucleotide and 
the amino acid sequence data also indicate that the 
first AUG triplet of the haemagglutinin RNA tran- 
script is indeed the initiating codon and they, there- 
fore, imply that the 5’-terminal extensions present on 
those influenza virus RNA transcripts which function 
as messenger RNAs [lo] are not translated. 
Similar results to the nucleotide sequence presented 
here have been obtained by analysis of complemen- 
tary DNA preparation by Dr G. Air (personal com- 
munication~. 
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